Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04408040 · ClinicalTrials.gov registry record · Phase 2
Use of Convalescent Plasma for COVID-19
A Phase 2 study, sponsored by Northside Hospital.
- Terminated
- Registry status
- Phase 2
- Development phase
- 8
- Enrollment target
NCT04408040 is a Phase 2 study that was terminated before completion, run by Northside Hospital. The registered enrollment target is 8 participants.
The verdict
NCT04408040, a Phase 2 study, was terminated before completion, sponsored by Northside Hospital.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 8 participants
- Enrollment target
Study Summary
The plan is to transfuse COVID-19 infected patients with convalescent plasma and observe whether this will result in a significant improvement in clinical outcome in comparison to historical experience.
Interventions
- BIOLOGICAL Convalescent Plasma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-07-14 |
| Est. Completion | 2021-09-14 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04408040
The ClinicalTrials.gov registry entry for NCT04408040 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northside Hospital, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Convalescent Plasma is the first listed.
NCT04408040 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04408040 about?
NCT04408040 is a clinical study titled "Use of Convalescent Plasma for COVID-19". The plan is to transfuse COVID-19 infected patients with convalescent plasma and observe whether this will result in a significant improvement in clinical outcome in comparison to historical experience.
What is the current status of trial NCT04408040?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 8 participants. The study started on 2020-07-14. Estimated completion is 2021-09-14.
What interventions are being tested in trial NCT04408040?
The interventions under investigation include: Convalescent Plasma (BIOLOGICAL).
Who is sponsoring clinical trial NCT04408040?
This trial is sponsored by Northside Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.